About CareZ
Your home for Alpha-1 information and physical, financial, and emotional support
CSL Behring understands that Alpha-1 patients have needs that go beyond just medicine.
Through its dedicated CareZ community, CSL Behring is able to provide the information
and support patients need to deal with the questions, concerns, and physical and
financial challenges that come with diagnosis of a chronic condition like Alpha-1–associated
emphysema.
- What causes Alpha-1?
- How common is it?
- How is it inherited?
- How is it diagnosed?
- Physical Fitness
Find out more about the My Steps for Healthy Living program
- Financial Support
Learn about the financial services available that can help ensure continuity of
care
- Emotional Support*
Read about our team of Patient Support Specialists and Personal Mentors –
people with Alpha-1 (also known as Alphas) who are trained and ready to help you
manage different challenges associated with the condition
Important Safety Information
Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.
Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).
Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.